A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies

Mise à jour : Il y a 4 ans
Référence : NCT01470209

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study will assess the safety of combining two agents (everolimus and BKM120) for the treatment of advanced cancer arising from solid organ in patients who are no longer benefiting from or unable to withstand standard treatment of these conditions.


Critère d'inclusion

  • Solid Tumors,Lung cancer

Liens